New ‘vaccine-like’ HIV drug could cost just $40: researchers – Times of India
PARIS: A new ‘vaccine-like’ HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.The antiretroviral drug Lenacapavir, developed by US pharmaceutical giant Gilead, has been hailed as a potential game-changer in the […]
Top Story
